title: Reply to Richie and Villasante.
authors.forename: Ann
authors.initials: A
authors.lastname: Duerr
authors.forename: Yunda
authors.initials: Y
authors.lastname: Huang
authors.forename: Susan
authors.initials: S
authors.lastname: Buchbinder
authors.forename: Robert W
authors.initials: RW
authors.lastname: Coombs
authors.forename: Jorge
authors.initials: J
authors.lastname: Sanchez
authors.forename: Carlos
authors.initials: C
authors.lastname: del Rio
authors.forename: Martin
authors.initials: M
authors.lastname: Casapia
authors.forename: Steven
authors.initials: S
authors.lastname: Santiago
authors.forename: Ying
authors.initials: Y
authors.lastname: Huang
authors.forename: Peter
authors.initials: P
authors.lastname: Gilbert
authors.forename: Lawrence
authors.initials: L
authors.lastname: Corey
authors.forename: Michael N
authors.initials: MN
authors.lastname: Robertson
mesh_terms: D016915:AIDS Vaccines / Q000276:immunology*; D005260:Female; D015658:HIV Infections / Q000517:prevention & control*; D015497:HIV-1 / Q000276:immunology*; D006801:Humans; D008297:Male
chemical_list: D016915:AIDS Vaccines